newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces Approval for Nasdaq Stock Market Listing

NEW YORK, June 7, 2021 /PRNewswire/ -- Synaptogenix, Inc. (OTC:SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, announced today that it has been approved to uplist to The Nasdaq Capital Market